These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20840479)

  • 1. Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury.
    Crikis S; Lu B; Murray-Segal LM; Selan C; Robson SC; D'Apice AJ; Nandurkar HH; Cowan PJ; Dwyer KM
    Am J Transplant; 2010 Dec; 10(12):2586-95. PubMed ID: 20840479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Differential Effect of Apyrase Treatment and hCD39 Overexpression on Chronic Renal Fibrosis After Ischemia-Reperfusion Injury.
    Roberts V; Campbell DJ; Lu B; Chia J; Cowan PJ; Dwyer KM
    Transplantation; 2017 Jul; 101(7):e194-e204. PubMed ID: 28198766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
    Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
    Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency or inhibition of CD73 protects in mild kidney ischemia-reperfusion injury.
    Rajakumar SV; Lu B; Crikis S; Robson SC; d'Apice AJ; Cowan PJ; Dwyer KM
    Transplantation; 2010 Dec; 90(12):1260-4. PubMed ID: 21063242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic swine: expression of human CD39 protects against myocardial injury.
    Wheeler DG; Joseph ME; Mahamud SD; Aurand WL; Mohler PJ; Pompili VJ; Dwyer KM; Nottle MB; Harrison SJ; d'Apice AJ; Robson SC; Cowan PJ; Gumina RJ
    J Mol Cell Cardiol; 2012 May; 52(5):958-61. PubMed ID: 22269791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
    Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of purinergic signaling on renal ischemia-reperfusion injury.
    Lu B; Rajakumar SV; Robson SC; Lee EK; Crikis S; d'Apice AJ; Cowan PJ; Dwyer KM
    Transplantation; 2008 Dec; 86(12):1707-12. PubMed ID: 19104409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemic Cerebroprotection Conferred by Myeloid Lineage-Restricted or Global CD39 Transgene Expression.
    Baek AE; Sutton NR; Petrovic-Djergovic D; Liao H; Ray JJ; Park J; Kanthi Y; Pinsky DJ
    Circulation; 2017 Jun; 135(24):2389-2402. PubMed ID: 28377485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD39 expression by hepatic myeloid dendritic cells attenuates inflammation in liver transplant ischemia-reperfusion injury in mice.
    Yoshida O; Kimura S; Jackson EK; Robson SC; Geller DA; Murase N; Thomson AW
    Hepatology; 2013 Dec; 58(6):2163-75. PubMed ID: 23813862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice.
    Beldi G; Banz Y; Kroemer A; Sun X; Wu Y; Graubardt N; Rellstab A; Nowak M; Enjyoji K; Li X; Junger WG; Candinas D; Robson SC
    Hepatology; 2010 May; 51(5):1702-11. PubMed ID: 20146261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation.
    Dwyer KM; Robson SC; Nandurkar HH; Campbell DJ; Gock H; Murray-Segal LJ; Fisicaro N; Mysore TB; Kaczmarek E; Cowan PJ; d'Apice AJ
    J Clin Invest; 2004 May; 113(10):1440-6. PubMed ID: 15146241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver grafts from CD39-overexpressing rodents are protected from ischemia reperfusion injury due to reduced numbers of resident CD4+ T cells.
    Pommey S; Lu B; McRae J; Stagg J; Hill P; Salvaris E; Robson SC; d'Apice AJ; Cowan PJ; Dwyer KM
    Hepatology; 2013 Apr; 57(4):1597-606. PubMed ID: 22829222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury.
    Köhler D; Eckle T; Faigle M; Grenz A; Mittelbronn M; Laucher S; Hart ML; Robson SC; Müller CE; Eltzschig HK
    Circulation; 2007 Oct; 116(16):1784-94. PubMed ID: 17909107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of cardiac-specific expression of CD39 on myocardial infarct size in mice.
    Smith SB; Xu Z; Novitskaya T; Zhang B; Chepurko E; Pu XA; Wheeler DG; Ziolo M; Gumina RJ
    Life Sci; 2017 Jun; 179():54-59. PubMed ID: 27756600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cells participate in CD39-mediated protection from renal injury.
    Wang YM; McRae JL; Robson SC; Cowan PJ; Zhang GY; Hu M; Polhill T; Wang Y; Zheng G; Wang Y; Lee VW; Unwin RJ; Harris DC; Dwyer KM; Alexander SI
    Eur J Immunol; 2012 Sep; 42(9):2441-51. PubMed ID: 22684996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.
    Hart ML; Gorzolla IC; Schittenhelm J; Robson SC; Eltzschig HK
    J Immunol; 2010 Apr; 184(7):4017-24. PubMed ID: 20207994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury.
    Grenz A; Zhang H; Hermes M; Eckle T; Klingel K; Huang DY; Müller CE; Robson SC; Osswald H; Eltzschig HK
    FASEB J; 2007 Sep; 21(11):2863-73. PubMed ID: 17442731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CD39-adenosinergic axis in the pathogenesis of renal ischemia-reperfusion injury.
    Roberts V; Lu B; Rajakumar S; Cowan PJ; Dwyer KM
    Purinergic Signal; 2013 Jun; 9(2):135-43. PubMed ID: 23188420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury.
    Sashindranath M; Dwyer KM; Dezfouli S; Selan C; Crikis S; Lu B; Yuan Y; Hickey MJ; Peter K; Robson SC; Cowan PJ; Nandurkar HH
    Purinergic Signal; 2017 Jun; 13(2):259-265. PubMed ID: 28343356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation.
    Robson SC; Wu Y; Sun X; Knosalla C; Dwyer K; Enjyoji K
    Semin Thromb Hemost; 2005 Apr; 31(2):217-33. PubMed ID: 15852225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.